White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers
Hypertensive disorders of pregnancy are a worldwide health problem for women. They cause complications in up to 10% of pregnancies and are associated with increased maternal and neonatal morbidity and mortality. Traditional blood pressure measurement in clinical practice is the most commonly used pr...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2023-08-01
|
| Series: | Folia Medica |
| Online Access: | https://foliamedica.bg/article/99159/download/pdf/ |
| _version_ | 1797726111447121920 |
|---|---|
| author | Vasilii S. Chulkov Ekaterina Nikolenko Vladislav Chulkov Anastasia Podzolko |
| author_facet | Vasilii S. Chulkov Ekaterina Nikolenko Vladislav Chulkov Anastasia Podzolko |
| author_sort | Vasilii S. Chulkov |
| collection | DOAJ |
| description | Hypertensive disorders of pregnancy are a worldwide health problem for women. They cause complications in up to 10% of pregnancies and are associated with increased maternal and neonatal morbidity and mortality. Traditional blood pressure measurement in clinical practice is the most commonly used procedure for diagnosing and monitoring hypertension treatment, but it is prone to significant inaccuracies caused, on the one hand, by the inherent variability of blood pressure and, on the other, by errors arising from measurement technique and conditions. Some studies have demonstrated a better estimate of the prognosis for the development of cardiovascular diseases using ambulatory blood pressure monitoring. We can detect white-coat hypertension using this method, which helps to avoid overdiagnosis and overtreatment in many cases, and we can also detect masked hypertension, which helps to avoid underdiagnosis and a lack of prescribed treatment if needed. White-coat hypertension is not a benign condition – it has been shown to be associated with higher risks of developing preeclampsia, preterm birth, and small-for-gestational-age babies. In this regard, it is extremely important for clinicians to be aware of the risk factors and outcomes associated with this condition. Pregnant women should be medically monitored both during pregnancy and after delivery to detect target organ damage, cardiovascular risk factors, or a metabolic syndrome. |
| first_indexed | 2024-03-12T10:41:06Z |
| format | Article |
| id | doaj.art-d038ce6bb1774fc5a8783a1d832ef5eb |
| institution | Directory Open Access Journal |
| issn | 1314-2143 |
| language | English |
| last_indexed | 2024-03-12T10:41:06Z |
| publishDate | 2023-08-01 |
| publisher | Pensoft Publishers |
| record_format | Article |
| series | Folia Medica |
| spelling | doaj.art-d038ce6bb1774fc5a8783a1d832ef5eb2023-09-02T08:11:11ZengPensoft PublishersFolia Medica1314-21432023-08-0165453954510.3897/folmed.65.e9915999159White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkersVasilii S. Chulkov0Ekaterina Nikolenko1Vladislav Chulkov2Anastasia Podzolko3Yaroslav-the-Wise Novgorod State UniversitySouth-Ural State Medical UniversitySouth-Ural State Medical UniversitySouth-Ural State Medical UniversityHypertensive disorders of pregnancy are a worldwide health problem for women. They cause complications in up to 10% of pregnancies and are associated with increased maternal and neonatal morbidity and mortality. Traditional blood pressure measurement in clinical practice is the most commonly used procedure for diagnosing and monitoring hypertension treatment, but it is prone to significant inaccuracies caused, on the one hand, by the inherent variability of blood pressure and, on the other, by errors arising from measurement technique and conditions. Some studies have demonstrated a better estimate of the prognosis for the development of cardiovascular diseases using ambulatory blood pressure monitoring. We can detect white-coat hypertension using this method, which helps to avoid overdiagnosis and overtreatment in many cases, and we can also detect masked hypertension, which helps to avoid underdiagnosis and a lack of prescribed treatment if needed. White-coat hypertension is not a benign condition – it has been shown to be associated with higher risks of developing preeclampsia, preterm birth, and small-for-gestational-age babies. In this regard, it is extremely important for clinicians to be aware of the risk factors and outcomes associated with this condition. Pregnant women should be medically monitored both during pregnancy and after delivery to detect target organ damage, cardiovascular risk factors, or a metabolic syndrome.https://foliamedica.bg/article/99159/download/pdf/ |
| spellingShingle | Vasilii S. Chulkov Ekaterina Nikolenko Vladislav Chulkov Anastasia Podzolko White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers Folia Medica |
| title | White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers |
| title_full | White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers |
| title_fullStr | White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers |
| title_full_unstemmed | White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers |
| title_short | White-coat hypertension in pregnant women: risk factors, pregnancy outcomes, and biomarkers |
| title_sort | white coat hypertension in pregnant women risk factors pregnancy outcomes and biomarkers |
| url | https://foliamedica.bg/article/99159/download/pdf/ |
| work_keys_str_mv | AT vasiliischulkov whitecoathypertensioninpregnantwomenriskfactorspregnancyoutcomesandbiomarkers AT ekaterinanikolenko whitecoathypertensioninpregnantwomenriskfactorspregnancyoutcomesandbiomarkers AT vladislavchulkov whitecoathypertensioninpregnantwomenriskfactorspregnancyoutcomesandbiomarkers AT anastasiapodzolko whitecoathypertensioninpregnantwomenriskfactorspregnancyoutcomesandbiomarkers |